Powered by

Novacyt S.A.: Half-Year Trading Update

Jul 30, 2019 - Business Wire

Regulatory News:

Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an unaudited half year revenue update for the six months ended 30 June 2019.

Unaudited revenues for the first half of 2019 were (EURO)7.2m compared to the restated revenues for 2018 of (EURO)6.4m, with strong growth from Primerdesign, the Group's molecular diagnostics business. Continuing Group revenue excluding NOVAprepĀ®, increased by 12% (11% CER) with peak ...